Evidence map›Paper›PMID 31323660›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2020

Chronic adolescent exposure to ∆9-tetrahydrocannabinol decreases NMDA current and extrasynaptic plasmalemmal density of NMDA GluN1 subunits in the prelimbic cortex of adult male mice.

Virginia M Pickel, Faye Bourie, June Chan, Ken Mackie, Diane A Lane, Gang Wang

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Adolescent administration of ΔIBRO neuroscience reports · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Virginia M PickelFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, 10065, USA. vpickel@med.cornell.edu.
Faye BourieFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, 10065, USA.
June ChanFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, 10065, USA.
Ken MackieLinda and Jack Gill Center for Biomolecular Science, Dept. of Psychological and Brain Sciences, Indiana University, Bloomington, IN, 47404, USA.
Diane A LaneFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, 10065, USA.
Gang WangFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, 10065, USA.
Cornell University · USMIND Research Institute · USIndiana University Bloomington · USWeill Cornell Medicine · US

Funding

Aberrant prefrontal cortical plasticity and neurobehavioral consequences of adolescent marijuanaR01DA042943 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI PICKEL, VIRGINIA M · 2017 to 2021
$2.0M
Sex-specific critical periods determine the effects of cannabinoids on the mesocorticolimbic systemR01DA043982 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI MACKIE, KENNETH, MANZONI, OLIVIER JJ · 2017 to 2021
$1.5M
NIDA NIH HHS R01 DA042943NIDA NIH HHS R01 DA043982
6 · The paper itself

Abstract

Adolescence is a vulnerable period of development when limbic connection of the prefrontal cortex (PFC) involved in emotional processing may be rendered dysfunctional by chronic exposure to delta-9-tetrahydrocannabinol (∆9-THC), the major psychoactive compound in marijuana. Cannabinoid-1 receptors (CB1Rs) largely mediate the central neural effects of ∆9-THC and endocannabinoids that regulate NMDA receptor-dependent synaptic plasticity of glutamatergic synapses in the prelimbic prefrontal cortex (PL-PFC). Thus, chronic occupancy of CB1Rs by ∆9-THC during adolescence may competitively decrease the functional expression and activity of NMDA receptors in the mature PL-PFC. We used a multidisciplinary approach to test this hypothesis in adult C57BL/6J male mice that received vehicle or ∆9-THC in escalating doses (2.5-10 mg/kg/ip) through adolescence (postnatal day 29-43). In comparison with vehicle, the mice receiving ∆9-THC showed a hyperpolarized resting membrane potential, decreased spontaneous firing rate, increased current-induced firing threshold, and decreased depolarizing response to NMDA in deep-layer PL-PFC neurons analyzed by current-clamp recordings. Electron microscopic immunolabeling in the PL-PFC of adult mice that had received Δ9-THC only during adolescence showed a significant (1) decrease in the extrasynaptic plasmalemmal density of obligatory GluN1-NMDA subunits in dendrites of all sizes and (2) a shift from cytoplasmic to plasmalemmal distribution of GluN1 in large dendrites receiving mainly inhibitory-type synapses from CB1R-labeled terminals. From these results and concomitant behavioral studies, we conclude that social dysfunctions resulting from excessive intake of ∆9-THC in the increasingly available marijuana products used by male teens may largely reflect circuit defects in PL-PFC networks communicating through endocannabinoid-regulated NMDA receptors.

Indexed as

Age FactorsAnimalsCell MembraneDose-Response Relationship, DrugDronabinolMaleMiceMice, Inbred C57BLNerve Tissue ProteinsPrefrontal CortexProtein SubunitsPsychotropic DrugsReceptors, N-Methyl-D-AspartateSynapsesDronabinolGprin1 protein, mouseNerve Tissue ProteinsProtein SubunitsPsychotropic DrugsReceptors, N-Methyl-D-Aspartate

Identifiers

PMID31323660
PMCPMC6901492
OpenAlexW2963336181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.